A novel trained mesenchymal stromal cell-based therapy, HXB-319, effectively controls progressive glomerulonephritis in a murine lupus model

Authors

Institutions

Publication Details

Journal
Stem Cells
Published
2025-06-30
DOI
https://doi.org/10.1093/stmcls/sxaf040
Primary Topic
Mesenchymal stem cell research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel trained mesenchymal stromal cell-based therapy, HXB-319, effectively controls progressive glomerulonephritis in a murine lupus model

Kristin B. Highland, Jane Reese, Steven N. Emancipator, Scott F. Sieg et al.
Stem Cells
Mesenchymal stem cell research
article

A novel trained mesenchymal stromal cell-based therapy, HXB-319, effectively controls progressive glomerulonephritis in a murine lupus model

Kristin B. Highland, Jane Reese, Steven N. Emancipator, Scott F. Sieg, Hülya Bükülmez, Adrienne T. Dennis, Sarah Kleinsorge-Block
article en

Abstract

No abstract available for this paper.
Stem CellsVol. 43(9)
Cleveland Clinic (US), MetroHealth Medical Center (US), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 78%
Mesenchymal stem cell research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A novel trained mesenchymal stromal cell-based therapy, HXB-319, effectively controls progressive glomerulonephritis in a murine lupus model — Kristin B. Highland, Jane Reese, et al. · Stem Cells (2025) | TGRS Research Map | TGRS